These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16927607)

  • 21. Punding in patients on dopamine agonists for restless leg syndrome.
    Evans AH; Stegeman JR
    Mov Disord; 2009 Jan; 24(1):140-1. PubMed ID: 18855926
    [No Abstract]   [Full Text] [Related]  

  • 22. Sleep attacks in patients receiving dopamine-receptor agonists.
    Plowman BK; Boggie DT; Morreale AP; Schaefer MG; Delattre ML; Chan H
    Am J Health Syst Pharm; 2005 Mar; 62(5):537-40. PubMed ID: 15745920
    [No Abstract]   [Full Text] [Related]  

  • 23. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restless legs syndrome.
    Gálvez-Jiménez N; Khan T; Hanson M
    Neurology; 1999 Jul; 53(2):439-40. PubMed ID: 10430455
    [No Abstract]   [Full Text] [Related]  

  • 25. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
    Quilici S; Abrams KR; Nicolas A; Martin M; Petit C; Lleu PL; Finnern HW
    Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restless legs syndrome.
    Bayard M; Avonda T; Wadzinski J
    Am Fam Physician; 2008 Jul; 78(2):235-40. PubMed ID: 18697508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restless leg syndrome, dopamine agonists and sleep attacks.
    Rose AR; Antic NA; McEvoy RD
    Intern Med J; 2008 Nov; 38(11):872-3. PubMed ID: 19120542
    [No Abstract]   [Full Text] [Related]  

  • 28. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of restless leg syndrome with pergolide.
    Gunning K; Gay C
    J Fam Pract; 1999 Apr; 48(4):250. PubMed ID: 10229243
    [No Abstract]   [Full Text] [Related]  

  • 30. Restless arm symptoms as an extension of restless leg syndrome.
    Alisky JM
    Age Ageing; 2007 Jan; 36(1):107. PubMed ID: 17114204
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of ropinirol ++ as a treatment for restless leg syndrome].
    Estivill E; de la Fuente V
    Rev Neurol; 1999 May 16-31; 28(10):962-3. PubMed ID: 10416230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model.
    Luo F; Li C; Ondo WG; Xu P; Xie W; Le W
    Sleep Med; 2011 Jan; 12(1):41-6. PubMed ID: 21044864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis.
    Miranda M; Kagi M; Fabres L; Aguilera L; Alvo M; Elgueta L; Erazo S; Venegas P
    Neurology; 2004 Mar; 62(5):831-2. PubMed ID: 15007148
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical experience with pramipexole in the treatment of restless legs syndrome.
    Merlino G; Serafini A; Robiony F; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):225-35. PubMed ID: 18248314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of restless legs syndrome: a familial case study.
    Snider S
    J Neurosci Nurs; 2013 Dec; 45(6):371-4. PubMed ID: 24217148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restless legs symptoms in a patient with above knee amputations: a case of phantom restless legs.
    Hanna PA; Kumar S; Walters AS
    Clin Neuropharmacol; 2004; 27(2):87-9. PubMed ID: 15252270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L; Ritchie SY; Kirsch JM
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurophysiology of the alternating leg muscle activation (ALMA) during sleep: study of one patient before and after treatment with pramipexole.
    Cosentino FI; Iero I; Lanuzza B; Tripodi M; Ferri R
    Sleep Med; 2006 Jan; 7(1):63-71. PubMed ID: 16310410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The restless legs syndrome can be treated with dopamine agonists].
    van Dijk N; Vogels OJ
    Ned Tijdschr Geneeskd; 2006 Dec; 150(52):2895; author reply 2895. PubMed ID: 17319225
    [No Abstract]   [Full Text] [Related]  

  • 40. [When L-Dopa preparations, dopamine agonists or opioids? Therapy of restless legs syndrome].
    Tings T; Trenkwalder C
    MMW Fortschr Med; 2003 Mar; 145(10):48-9. PubMed ID: 12688028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.